Leaflet RABIPUR INACTIVATED RABIES VACCINE FOR HUMAN USE 2.5UI / ml lyophilized powder and solvent for intradermic injection solution
Indicated for: prevention of rabies
Route of administration: intradermal
Substance: rabies vaccine inactivated (vaccine)
ATC: J07BG01 (Antiinfectives for systemic use | Viral vaccines | Rabies vaccines)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Store in the refrigerator as instructed in the leaflet.
Store protected from light.
The inactivated rabies vaccine is used to prevent rabies, a fatal viral disease caused by the rabies virus, which is transmitted through the bite or scratch of an infected animal. The vaccine contains inactivated (killed) viruses that stimulate the immune system to produce antibodies against the virus, providing protection against infection.
The vaccine is administered intramuscularly, either as pre-exposure prophylaxis for individuals at high risk (such as veterinarians or travelers to endemic areas) or as post-exposure prophylaxis after contact with a suspected animal. The vaccination schedule varies depending on the situation, typically including 3-5 doses.
Common side effects include pain at the injection site, fever, headache, and fatigue. In rare cases, severe allergic reactions or neurological symptoms may occur.
The inactivated rabies vaccine is an essential measure for preventing rabies, helping to save lives and reduce the incidence of this fatal disease.
General data about RABIPUR INACTIVATED RABIES VACCINE FOR HUMAN USE 2.5UI / ml
- Substance: rabies vaccine inactivated
- Date of latest medicines list: 01-08-2018
- Product code: W64418001
- Concentration: 2.5UI / ml
- Pharmaceutical form: lyophilized powder and solvent for intradermic injection solution
- Quantity: 1
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.